Prerpints.org logo
Preprint
Review

The Structure of the Cardiac Mitochondria Respirasome Is Adapted for the β‐Oxidation of Fatty Acids

Altmetrics

Downloads

108

Views

52

Comments

0

A peer-reviewed article of this preprint also exists.

This version is not peer-reviewed

Submitted:

27 December 2023

Posted:

28 December 2023

You are already at the latest version

Alerts
Abstract
The single set of electron transporters of the cardiac mitochondrial respiratory chain is organized into three separate supercomplexes. Two of them contain complex I, a dimer of complex III, and two dimers of complex IV. The third supercomplex contains a dimer of complex III and two dimers of complex IV. We also considered two important discoveries. First, the enzymes of β-oxidation of fatty acids are physically associated with respirasome. Second, β-oxidation of fatty acids creates the highest level of QH2 and reverses the flow of electrons from QH2 through complex II, reducing fumarate to succinate. We argue that the respirasome is uniquely adapted for the β-oxidation of fatty acids. The acyl-CoA dehydrogenase complex reduces the membrane’s pool of ubiquinone to QH2, which is instantly oxidized by the 2complex III-4complex IV supercomplex, generating high energization of mitochondria and reversing the electrons flow through the complex II, which reverses the electrons flow through the complex I increasing the NADH/NAD+ ratio in the matrix. The mitochondrial nicotinamide nucleotide transhydrogenase catalyzes a hydride (H-, a proton plus two electrons) transfer across the inner mitochondrial membrane, reducing the cytosolic pool of NADP(H), thus providing the heart with ATP for muscle contraction and energy and reducing equivalents for the housekeeping processes.
Keywords: 
Subject: Biology and Life Sciences  -   Biochemistry and Molecular Biology

1. Introduction

In the 60s of the 20th century, physiologists have shown that in the heart and kidneys, β-oxidation of the long-chain fatty acids (FAs) provides more than 90% of energy for ATP production [1–4]. However, researchers studying respiratory activities of the isolated mitochondria relatively rarely used long-chain fatty acids as substrates. In comparison with other commonly used respiratory substrates, which are products of carbohydrates or amino acids catabolism, fatty acids are much more complicated as substrates for mitochondria. They are divided into short-chain (C2-C4), middle-chain (C6 – C12), and long-chain (C14-C20) according to the length of the aliphatic chain, they may have different numbers of double bonds. Different organs may have different propensities to the oxidation of fatty acids and preference to the length of the carbon chain. Polyunsaturated long-chain fatty acids have important biological roles and, therefore, are not oxidized by the mitochondria. It is not surprising that there is great controversy regarding the oxidation of fatty acids and different opinions regarding their role in different organs as a source of energy.
The situation with mitochondrial respiration became even more complicated after it was discovered that the respiratory chain is organized into three supercomplexes, which together make up a more complex structure named respirasome [5–7]. The physiological and functional significance of respirasome could not be understood from our previous experimental information about the structure and function of the mitochondrial respiratory chain (Figure 1). We must admit that almost everything we know about the structure and functions of respiration is incorrect. For many decades, we did too many things to distort the truth. Here are several examples: 1) More than 80% of our knowledge about mitochondria was obtained by studying liver mitochondria – cheap and quick. It is not surprising that many scientists regard liver mitochondria as the standard for what mitochondria from other organs should be. However, liver mitochondria from the starved animals do not oxidize pyruvate, and researchers used either glutamate or, more often, succinate + rotenone instead of fatty acids. In addition, the liver has many unique functions and, therefore, cannot serve as a standard for mitochondria from other organs. 2) In experiments with the isolated mitochondria, researchers practically always used a single substrate, sometimes with malate, whereas in vivo mitochondria oxidize substrates from several metabolic pathways simultaneously. 3) The energy metabolism of most organs was considered and studied from the perspective of the tricarboxylic acid cycle. Thus, it is believed that brain mitochondria can utilize only glucose or lactate as the main energy source [8]. However, it was established that even the isolated brain synaptic mitochondria, as well as the heart and kidney mitochondria, perfectly oxidize long-chain FAs in the presence of succinate, glutamate, or pyruvate [9–13]. 4) In experiments with isolated mitochondria, many researchers assigned pyruvate and glutamate as substrates for complex I and succinate for complex II. However, glutamate dehydrogenase is located mostly in hepatocytes, whereas in other organs, the predominant oxidation of glutamate and often pyruvate occurs via the transamination pathway with the formation of succinate [14].
Of course, during previous decades, many great discoveries were made. However, as a goal, mitochondrial and cellular physiology were excluded from the in vitro experiments. Most importantly, the selection of substrates and often incubation conditions were far from the real conditions in the organs. In our publications, we have stressed that only long-chain fatty acids can maintain high rates of ATP production for a long period of time [10–13,15]. In this work, we propose that in the heart, the respirasome is evolutionary adapted for the effective oxidation of long-chain and middle-chain fatty acids to maintain high rates of ATP production and also to stimulate anabolic and anaplerotic metabolic pathways in the hard-working organs, such as the heart, kidneys, brain, and skeletal muscles.
We also must explain the high self-citation: It happened that for the last 15 years, the author and his colleagues Sergey Dikalov and Vladimir Mayorov were the only ones who studied fatty acid β-oxidation in the presence of supporting substrates.

2. The superstructural organization of the respiratory chain.

Back in the early 80s of the twentieth century, it was shown that a single set of respiratory complexes and ATP synthases for cardiac mitochondria has the following ratios: complexes I:II:III:IV:V relate as 1:2:3:6–7:3–5 [16]. These ratios could not be understood in terms of existing models of the respiratory chain structure shown in Figure 1.
Figure 1 and similar presentations of the respiratory chain indicate only the principal sequence of electron movement along the respiratory chain and are generally misleading. In 2000, it was shown that the single set of electron carriers is organized into three supercomplexes together, forming a functional unit named respirasome [5,6]. Each of the two large supercomplexes comprises one complex I associated with one dimer (two copies) of complex III connected with two dimers of complex IV (four copies). The third, smaller supercomplex contains one dimer of complex III associated with two dimers of complex IV (Figure 2).
Since Schagger's publications about the organization of the respiratory chain into three main supercomplexes, many papers have been published regarding various aspects of the supercomplexes. From the literature, it becomes apparent that the term “respirasome’s superstructure” describes a phenomenon of formation of membrane-bound clusters of respiratory complexes rather than entities with a well-defined composition [18]. Dudkina et al. (2010) named these clusters “respiratory string” [19]
Nesterov et al. (2022, 2023) developed a dynamics model of long-range transport of energized protons along the mitochondrial inner membrane accompanied by collective excitation of localized waves propagating on the membrane surface. This model is based on the new data on the macromolecular organization of the OXPHOS system, showing the well-ordered structure of respirasomes and ATP synthases on the cristae membrane folds (Figure 4) [20,21].
An analysis of the state of respirasomes in patients with an isolated deficiency of single complexes suggests that forming respirasomes is important for the assembly/stability of complex I, the major entry point of respiratory chain substrates. Genetic alterations leading to a loss of complex III prevented respirasome formation and led to the secondary loss of complex I [22]. Only a few of the published papers specifically mentioned the physiological role of the respirasome. Still, they discussed the transport of electrons from the perspective of glucose metabolism (pyruvate) and the Krebs cycle [23]. Some of the authors recognized that the physiological significance of the respirasome superstructure remains an enigma [24,25,26]. How respirasome might participate in the β-oxidation of long-chain FAs was not even mentioned.

3. The structural-functional properties of the cardiac mitochondrial respirasome evidence that the respirasome is specifically adapted for the β-oxidation of fatty acids.

All authors, however, who studied the properties of respiratory supercomplexes in different species recognize that these structures are highly dynamic and evidently can accommodate the particular metabolic demands of the species [18,25,26,27]. Accepting this point of view and the established structure of the heart mitochondria respirasome [5,6], let us think about the heart's metabolic demands. We know: 1) The heart works constantly and consumes huge amounts of ATP, and this requires substrates that last long; fatty acids are the only choice. 2) The heart works in a wide range of functional loads. 3) The heart’s cardiomyocytes, to a large degree, work as a syncytium [28]. 4) About 95% of energy cardiomyocytes are obtained from β-oxidation of long-chain fatty acids [1]. 5) Two enzyme complexes responsible for the β-oxidation of fatty acids are physically attached to the respirasome [29]. Considering that the electron-transporting complexes that constitute the respirasome’s supercomplexes are tightly packed [19,20,21], physical contact with the beta-oxidation enzymes will promote the reduction/oxidation cycle of the membrane's ubiquinone pool.
It is evident that the smaller supercomplex, with the active centers of the complex III dimer open inside the inner mitochondrial membrane, uses the reduced coenzyme Q (ubiquinol) as the source of hydrogen. Oxidation of ubiquinol occurs at a very high rate. The two larger supercomplexes utilize acetyl-CoA produced by the trifunctional protein of the FAs oxidation system or by decarboxylation of the glycolytic pyruvate, as well as the substrates of the tricarboxylic cycle, as the source of hydrogen in the form of NADH + H+.
The reduction of the membrane pool of Co-Q to Co-QН2 occurs during the β-oxidation of FAs via the work of FAD-containing enzymes of the acyl-CoA dehydrogenase complex (Figure 5) and by succinate dehydrogenase, also known as Complex II. In the liver and the islet cells of the pancreas, glycerol-3-phosphate may be involved in reducing the membrane’s ubiquinone. However, this pathway of ubiquinone reduction does not play an essential role in the brain, heart, kidneys, and white fat tissue [30].
The highest rates of reduction of ubiquinone to ubiquinol occur in the organs, where the β-oxidation of long-chain fatty acids is the main source of energy. Correspondingly, in these organs, the highest stationary levels [QН2] are maintained [31].

3.1. In the absence of β-oxidation of long-chain and middle-chain fatty acids, the respirasome predominantly supports the catabolic reactions.

Figure 6 presents a metabolic situation typically occurring during the in vitro experiments with the isolated mitochondria oxidizing any substrates but fatty acids. Without β-oxidation of fatty acids, the TCA cycle enzyme succinate dehydrogenase (SDH) is the only source of ubiquinol (QH2) in mitochondria. Because the smaller subunit of respirasome lacks complex I, it directly interacts and instantly oxidizes the membrane’s ubiquinol. The extremely high rate of QН2 oxidation is directly associated with the structure of the smaller respirasome subunit, which has two active centers at the dimer of complex III, each of which reacts with a dimer of complex IV that catalyzes the irreversible reaction of water formation and releases a large portion of energy as heat. This is the point of irreversibility for mitochondrial energy metabolism.
However, in vivo, the resources of succinate are too small to become the main substrate for energization. Therefore, the maximal respiration rate is limited by the rate of succinate formation. Other mitochondrial metabolites, which are formed or metabolized after entering the tricarboxylic acid cycle (see Figure 6), provide electrons to the respiratory chain in the form of NADH + H+. It is a well-established fact that the NADH dehydrogenase of complex I is the rate-limiting step in mitochondrial respiration based on the NAD-dependent substrates [14]. In addition, in the experiments in vitro, it was established that, particularly in the mitochondria isolated from the brain or heart, the rate of externally added succinate oxidation is controlled by the phenomenon called “the intrinsic inhibition of SDH.” The inhibition is caused by endogenous oxaloacetate, which is discussed more thoroughly in [31,32,33]. Notably, kidney mitochondria are the only ones in the human body where intrinsic inhibition of SDH is absent, and mitochondria can accumulate succinate [1,13].
Figure 7 presents respiratory rates of the isolated rat heart mitochondria oxidizing various substrates and their mixtures during resting (State 4), active ADP phosphorylation (State 3), and uncoupled respiration (State 3U).
Figure 7A, B, and C show that “classical substrates” for complex I provide only moderate rates of oxidative phosphorylation in the rat heart mitochondria. However, the inhibitor analysis has shown that in the brain and particularly in the heart mitochondria, these substrates are oxidized via transamination with the formation of α-ketoglutarate, which is further oxidized to succinate [14]. Figures 7D and 7E show that the intrinsic inhibition of succinate oxidation was abolished in the presence of pyruvate or glutamate. Figure 7F shows that palmitoyl-carnitine alone is a very bad substrate for the heart mitochondria. This was the reason why researchers almost never utilized acyl-carnitines as substrates for the heart mitochondria.
However, Figure 8A shows that when the two “bad” substrates succinate (Figure 7D) and palmitoyl-carnitine (7F) are added together, the respiration rates increase dramatically in all metabolic states. The rates of ADP phosphorylation increased to the maximum for this type of mitochondria. The respiration rates were also high when succinate was mixed with pyruvate or glutamate. As regards malate, we can mention that different animals, even from the same strain, respond differently upon the addition of malate: in some animals, malate increased the stimulatory effects of pyruvate or glutamate on succinate or palmitoyl-carnitine oxidation; in others, malate significantly inhibited these effects [35].
From the data presented in Figure 7 and Figure 8, we can suggest that in the absence of β-oxidation of FAs, the large supercomplexes of the respirasome functionally are not designed to support the high rates of ATP consumption as is in vivo in the heart, kidneys, and brain [14]. Only long-chain fatty acids can sustain high rates of ATP production for a long time [34].

3.2. β-oxidation of long-chain fatty acids in the presence of other mitochondrial substrates supports a high rate of ATP production and the anabolic metabolism in cardiomyocytes.

For the last 20 years, after discovering the respirasome’s structure, many researchers have studied various aspects of respirasome structure and function [18,19,20,21,22,23,24,25,26,27]. Unfortunately, most of these studies were based on old paradigms. They did not address the physiological aspects of the respirasome in the oxidation of the body’s main substrates, long-chain fatty acids. Meanwhile, other researchers made great discoveries, which also initially met little attention from other researchers but directly contributed to understanding mitochondrial energy metabolism. In 2010, it was shown that the enzymes of β-oxidation of long-chain FAs are physically attached to the respirasome [29]. Brand and his colleagues have shown that the highest stationary levels of ubiquinol are maintained in the organs, where the β-oxidation of long-chain fatty acids is the main energy source [31,32,33]. Moreover, Brand and his team discovered that at a high level of ubiquinol, succinate dehydrogenase reverses the flow of electrons from ubiquinol into mitochondria and reduces fumarate to succinate [31,32,33].
Finally, it has been shown that β-oxidation of the long-chain fatty acids requires, for achieving maximum rates, the simultaneous presence of other mitochondrial metabolites: succinate, glutamate, or pyruvate [11,34].
Figure 9 illustrates the situation when mitochondrial β-oxidation of l.c. FAs is the main source of mitochondrial energization. According to Brand, during β-oxidation of lcFAs, mitochondria reduce the matrix pool of NAD to NADH + H+ and the membrane's pool of ubiquinone to ubiquinol (QH2) [31,32,33]. It must be remembered that the enzymes involved in the β-oxidation of fatty acids are also arranged into two polyenzymatic complexes, which are physically associated with the respirasome [29]. The structure of the minor supercomplex of the respirasome allows oxidizing ubiquinol extremely fast and thus maintains the highest demands in ATP. Electrons from the QH2 at the respiratory complex II (SDH) become reversed, thus turning the TCA cycle function from the catabolic metabolic pathway to anabolic and anaplerotic pathways. In well-energized mitochondria, the excess electrons reduce components of complex I and thus accelerate the production of superoxide radicals [34,35]. Under these conditions, the SDH also produces ROS at a high rate [31,32,33]. This we have observed in experiments with the isolated mitochondria [34] when incubation conditions did not allow mitochondria to activate NNT. In situ, however, in the energized heart mitochondria, the activity of NTT will transfer the excessive energy into the cytoplasm and thus diminish or even prevent the formation of superoxide radicals.
At high mitochondrial energization, the large supercomplexes of the respirasome maintain anaplerotic reactions, such as aerobic gluconeogenesis [9] and anabolic processes in the cytoplasm, which require NADPH. Energy-dependent mitochondrial nicotinamide nucleotide transhydrogenase (NNT) maintains the cells' high NADPH/NADP+ ratio [36,37,38]. The primary role attributed to the forward NNT reaction is maintaining an elevated mitochondrial NADPH/NADP+ ratio. The mitochondrial NADPH supply is critical to support various physiological functions, including biosynthetic pathways, mtDNA replication and maintenance, and enzymatic systems involved in thiol reduction and peroxide detoxification [39]. The highest expression of NNT was observed in the heart and kidney, which utilize β-oxidation of FAs as the primary energy source [40].
Obviously, activation of anaplerotic and synthetic reactions in the cell will depend on the characteristics of fatty acids metabolism and functions of the organ. For example, in brain astrocytes, the oxidation of fatty acids ensures the activity of aerobic glycolysis and the formation of lactate, which is a direct substrate for brain neurons. The anaplerotic formation of glutamine is a source of neurotransmitters glutamate and GABA [9,10]. All of these metabolic pathways are irreversible due to the smaller supercomplex of the respirasome.

4. Stimulation of β-oxidation of fatty acids by supporting substrates.

We studied the effects of mitochondrial metabolites, which are by themselves substrates for mitochondrial respiration, on β-oxidation of palmitoyl-carnitine (a long-chain (C16) acyl-carnitine) using isolated mitochondria from three organs of a rat: heart, brain synapses, and kidney cortex as described in [11,34,35]. With palmitoyl-carnitine+ malate as substrate, brain and heart mitochondria had very low rates of ADP phosphorylation. With succinate alone, brain and heart mitochondria showed no stimulation of the State 3 respiration upon the addition of ADP. However, when the brain and heart mitochondria were oxidizing palmitoyl-carnitine and succinate simultaneously, the rates of the State 3 respiration were the highest and exceeded the State 3 respiratory rates for palmitoyl-carnitine + glutamate or palmitoyl-carnitine + pyruvate by 30-70% [34,35]. Remarkably, with the brain mitochondria, pyruvate was more effective in stimulating respiration with palmitoyl-carnitine than glutamate, whereas with the heart mitochondria, glutamate was more effective than pyruvate [34,35]. This coincides with the activities of glutamate-aspartate transaminase, which is higher in the heart as compared to the brain mitochondria.
Unlike the brain and heart mitochondria, kidney mitochondria lack the intrinsic inhibition of SDH and, therefore, oxidized succinate at very high rates. However, kidney mitochondria also showed low rates of respiration in all metabolic states with palmitoyl-carnitine + malate. The highest stimulation of palmitoyl-carnitine oxidation was observed with 5 mM succinate, whereas glutamate was much less effective than succinate, and pyruvate was completely ineffective. Because with the kidney cortex mitochondria, the State 3 succinate respiration rate was only 20-30% lower than with palmitoyl-carnitine + succinate, some of our colleagues doubted that succinate stimulated oxidation of palmitoyl-carnitine. SDH in kidney mitochondria has a very high Km for succinate; therefore, with 0.5 mM succinate, there was no respiration at all. However, 0.5 mM of succinate stimulated the rate of palmitoyl-carnitine oxidation 4-fold and that of octanoyl-carnitine 8-fold. These facts directly support the idea that succinate stimulates the β-oxidation of fatty acids. Moreover, the oxidation of fatty acids increases the concentration of ubiquinol and reverses the flow of electrons from QH2 to the TCA cycle, reducing fumarate to succinate [31]. Thus, kidneys accumulate succinate and may play a major role in the activation of the succinate-specific G-protein GPR91 [13].
These data support our working hypothesis that the stimulation of the palmitoyl-carnitine oxidation is exerted by succinate, and those of pyruvate and glutamate depend on the transamination activities of the organ’s mitochondria. We suggest that succinate somehow, possibly by the allosteric mechanism, promotes the reversal of the electron flow from ubiquinol to fumarate and further to the large supercomplexes, which contain complex I. This working hypothesis agrees with our proposal that the β-oxidation of long-chain and middle-chain fatty acids is the main function of respirasome.

5. Conclusions

The extensive work of many researchers allows us to appreciate a very complex organization of the mitochondrial oxidative phosphorylation system. Recent works on the mitochondrial respirasome, comprising three supercomplexes, suggest that the respiratory system for oxidation of a particular type of substrate has even higher orders of structural organization. In the case of β-oxidation of fatty acids, the respiratory system includes the physical association of the respirasome with the enzymes of β-oxidation of fatty acids [29] and succinate dehydrogenase of the TCA cycle (complex II) [40], which is a part of the TCA cycle. In its turn, the respiratory functional megacomplex is structurally coupled with the ATP-synthase complex, forming a functional megastructure of an even higher order [20,21,41,42].
Previous ideas about the respiratory chain, as a sequence of electron carriers from NADH to oxygen, did not explain how the heart fulfills energy-consuming needs that are beyond contractile function. In this review, we argue that in a typical in vitro experiment, mitochondria oxidizing any substrate except fatty acids exhibit only catabolic properties and rarely exhibit maximum rates of ATP synthesis (see Figure 7 and Figure 8). High energy-consuming organs, like the heart and kidneys, rely on fatty acid oxidation because this fuel source provides 106 ATP molecules compared to 36 from glucose metabolism [43]. Moreover, only β-oxidation of fatty acids can provide the maximum rates of ubiquinol formation and, thus, maximum rates of respiration, ATP production, and support synthetic and anaplerotic functions.
The structure and functions of the oxidative phosphorylation system are inextricably linked with the unique mitochondrial phospholipids: phosphatidyl ethanolamine and cardiolipin, in particular [20,21,40,41,42]. In the mitochondrial membrane, CL is involved in the organization of multi-subunit oxidative phosphorylation complexes and in their association with the supercomplexes of higher-order [44]. Thus, not only the dysfunctions of proteins and mutations of genes encoding them but also oxidative or metabolic abnormalities of mitochondrial phospholipids may cause many diseases [40,41].
The ability of CL to fit into the negative curvatures of the inner membranes explains the fact that about 80% of CL is located in the inner leaf of the inner mitochondrial membrane, where CL interacts with a large number of mitochondrial proteins, complexes, and supercomplexes of the respiratory chain, ATP-synthase, ATP/ADP carrier, uncoupling protein, etc. [45]. The rest of the CL (about 20% of the total CL) is located in the outer leaf of the IMM, which, in general, has a positive curvature but at the contacts of the outer leaf of the IMM, with the outer membrane, CL forms connecting complexes with negative curvature between the inner membrane and porin of the outer mitochondrial membranes, which also include various intermembrane and cytosolic enzymes, for example, сytochrome «c», hexokinase, creatine kinase, and ANT, that is enzymes specific for the metabolism of each organ [46]. These contact sites play an important role in the cristae organizing system and optimization of the organ's energy metabolism [47]. Strong negative charges allow CL to interact with the membrane’s proteins and peptides by electrostatic interactions. Because the headgroup of CL is very small and bound to two phosphatides, the conformational variabilities are strongly limited [48]. This restricts intermolecular interactions of the head’s OH groups of CL in the rafts and with other phospholipids but makes the head’s phosphates open to interactions with the matrix water, metal ions, peptides, proteins, and lipids, which are much stronger as compared with other membrane lipids. Interactions of CL with other proteins may be so strong that Cl was found in the crystals of the isolated proteins, for example, in the crystals of Complex III and ANT [48]. It is CL and FEA that are responsible for binding individual electron carriers into supercomplexes of the respirasome.
The anionic properties of cardiolipin and its concentration at negative curves of the cristae, where are localized supercomplexes of the respiratory system, result in local acidification of water layer close to the membrane. This increases the probability of the protonation of superoxide radicals produced by the respiratory supercomplexes and SDH [31]. The perhydroxyl radical (HO2•) specifically induces the isoprostane lipid peroxidation of polyunsaturated fatty acids that result in oxidative damage of cardiolipin and phosphatidyl ethanol amine that participate in formation and stabilization of the supercomplexes [49]. This is one of the most significant mechanisms of the organism's overall aging and the cause of age-associated diseases [50].

References

  1. Bertermann, H.; Gronow, G.; Schirmer, A.; Weiss, C. Contribution of long chain fatty acids to the energy supply of the rat kidney cortex. Pfl?gers Arch. Eur. J. Physiol. 1975, 356, 9–17. [Google Scholar] [CrossRef] [PubMed]
  2. Wirthensohn, G.; Guder, W.G. Triacylglycerol metabolism in isolated rat kidney cortex tubules. Biochem. J. 1980, 186, 317–324. [Google Scholar] [CrossRef] [PubMed]
  3. Spitzer, J.J. CNS, and fatty acid metabolism. Physiologist 1973, 55–68. [Google Scholar]
  4. Stanley, W.C.; Chandler, M.P. Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions. Hear. Fail. Rev. 2002, 7, 115–130. [Google Scholar] [CrossRef] [PubMed]
  5. Schägger, H. Respiratory Chain Supercomplexes. IUBMB Life 2001, 52, 119–128. [Google Scholar] [CrossRef] [PubMed]
  6. Schägger, H.; Pfeiffer, K. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J. 2000, 19, 1777–1783. [Google Scholar] [CrossRef] [PubMed]
  7. Schägger, H.; Pfeiffer, K. The Ratio of Oxidative Phosphorylation Complexes I–V in Bovine Heart Mitochondria and the Composition of Respiratory Chain Supercomplexes. J. Biol. Chem. 2001, 276, 37861–37867. [Google Scholar] [CrossRef] [PubMed]
  8. Magistretti, P.J.; Allaman, I. Lactate in the brain: from metabolic end-product to signalling molecule. Nat. Rev. Neurosci. 2018, 19, 235–249. [Google Scholar] [CrossRef]
  9. Panov, A.; Orynbayeva, Z.; Vavilin, V.; Lyakhovich, V. Fatty Acids in Energy Metabolism of the Central Nervous System. BioMed Res. Int. 2014, 2014, 472459. [Google Scholar] [CrossRef]
  10. Panov, A.; Dikalov, S. Brain energy Metabolism. In Encyclopedia in Biochemstry, 3rd ed.; Elsevier Inc.: Amsterdam, The Netherlands, 2021; pp. 1–16. [Google Scholar]
  11. Panov, A.V.; Mayorov, V.I.; Dikalov, S.I. Metabolic properties of murine kidney mitochondria. Preprint PLoS ONE 2021. [Google Scholar] [CrossRef]
  12. Panov, A.; Mayorov, V.I.; Dikalov, S. Metabolic Syndrome and β-oxidation of Long-Chain Fatty Acids in the Brain, Heart, and Kidney Mitochondria. Int. J. Mol. Sci. 2022, 23, 7. [Google Scholar] [CrossRef]
  13. Panov, A.V.; Mayorov, V.I.; Dikalova, A.E.; Dikalov, S.I. Long-Chain and Medium-Chain Fatty Acids in Energy Metabolism of Murine Kidney Mitochondria. Int. J. Mol. Sci. 2022, 24, 379. [Google Scholar] [CrossRef] [PubMed]
  14. Panov, A.V.; Dikalov, S.I.; Shalbuyeva, N.; Hemendinger, R.; Greenamyre, J.T.; Rosenfeld, J.; Ungvari, Z.; Nazarewicz, R.R.; Dikalova, A.E.; Bikineyeva, A.; et al. Species- and tissue-specific relationships between mitochondrial permeability transition and generation of ROS in brain and liver mitochondria of rats and mice. Am. J. Physiol. Physiol. 2007, 292, C708–C718. [Google Scholar] [CrossRef] [PubMed]
  15. Panov, A.V.; Darenskaya, M.A.; Dikalov, S.I.; Kolesnikov, S.I. Metabolic syndrome as the first stage of eldership; the beginning of real aging. In Update in Geriatrics. Intech Open, Editor Somchai Somarnyotin, 2021, pp. 37–67, ISBN: 978-1-83962-309-7.
  16. Hatefi, Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu. Rev. Biochem. 1985, 54, 1015–1069. [Google Scholar] [CrossRef]
  17. Hoffman, D.L.; Brookes, P.S. Oxygen Sensitivity of Mitochondrial Reactive Oxygen Species Generation Depends on Metabolic Conditions. J. Biol. Chem. 2009, 284, 16236–16245. [Google Scholar] [CrossRef] [PubMed]
  18. Brzezinski, P.; Moe, A.; Ädelroth, P. Structure and Mechanism of Respiratory III–IV Supercomplexes in Bioenergetic Membranes. Chem. Rev. 2021, 121, 9644–9673. [Google Scholar] [CrossRef]
  19. Dudkina, N.V.; Kouřil, R.; Peters, K.; Braun, H.-P.; Boekema, E.J. Structure and function of mitochondrial supercomplexes. Biochim. et Biophys. Acta (BBA) - Bioenerg. 2010, 1797, 664–670. [Google Scholar] [CrossRef]
  20. Nesterov, S.; Chesnokov, Y.; Kamyshinsky, R.; A Panteleeva, A.; Lyamzaev, K.; Vasilov, R.; Yaguzhinsky, L. Ordered Clusters of the Complete Oxidative Phosphorylation System in Cardiac Mitochondria. Int. J. Mol. Sci. 2021, 2021, 1462. [Google Scholar] [CrossRef]
  21. Nesterov, S.V.; Yaguzhinsky, L.S.; Vasilov, R.G.; Kadantsev, V.N.; Goltsov, A.N. Contribution of the Collective Excitations to the Coupled Proton and Energy Transport along Mitochondrial Cristae Membrane in Oxidative Phosphorylation System. Entropy 2022, 24, 1813. [Google Scholar] [CrossRef]
  22. Schägger, H.; de Coo, R.; Bauer, M.F.; Hofmann, S.; Godinot, C.; Brandt, U. Significance of Respirasomes for the Assembly/Stability of Human Respiratory Chain Complex I. J. Biol. Chem. 2004, 279, 36349–36353. [Google Scholar] [CrossRef]
  23. Sousa, J.S.; D'Imprima, E.; Vonck, J. Mitochondrial Respiratory Chain Complexes. Subcell. Biochem. 2018, 87, 167–227. [Google Scholar] [PubMed]
  24. Acín-Pérez, R.; Fernández-Silva, P.; Peleato, M.L.; Pérez-Martos, A.; Enriquez, J.A. Respiratory Active Mitochondrial Supercomplexes. Mol. Cell 2008, 32, 529–539. [Google Scholar] [CrossRef] [PubMed]
  25. Javadov, S.; Jang, S.; Chapa-Dubocq, X.R.; Khuchua, Z.; Camara, A.K. Mitochondrial respiratory supercomplexes in mammalian cells: structural versus functional role. J. Mol. Med. 2020, 99, 57–73. [Google Scholar] [CrossRef] [PubMed]
  26. Nath, S. Supercomplex supercomplexes: Raison d’etre and functional significance of supramolecular organization in oxidative phosphorylation. Biomol. Concepts 2022, 13, 272–288. [Google Scholar] [CrossRef] [PubMed]
  27. Chaban, Y.; Boekema, E.J.; Dudkina, N.V. Structures of mitochondrial oxidative phosphorylation supercomplexes and mechanisms for their stabilization. Biochim. Biophys. Acta 2014, 1837, 418–426. [Google Scholar] [CrossRef] [PubMed]
  28. Bernstein, S.A.; Morley, G.E. Gap junctions and propagation of the cardiac action potential. Adv. Cardiol. 2006, 42, 71–85. [Google Scholar]
  29. Wang, Y.; Mohsen, A.-W.; Mihalik, S.J.; Goetzman, E.S.; Vockley, J. Evidence for Physical Association of Mitochondrial Fatty Acid Oxidation and Oxidative Phosphorylation Complexes. J. Biol. Chem. 2010, 285, 29834–29841. [Google Scholar] [CrossRef] [PubMed]
  30. MacDonald, M. High content of mitochondrial glycerol-3-phosphate dehydrogenase in pancreatic islets and its inhibition by diazoxide. J. Biol. Chem. 1981, 256, 8287–8290. [Google Scholar] [CrossRef]
  31. Brand, M.D. Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radic. Biol. Med. 2016, 100, 14–31. [Google Scholar] [CrossRef]
  32. Perevoshchikova, I.V.; Quinlan, C.L.; Orr, A.L.; Gerencser, A.A.; Brand, M.D. Sites of superoxide and hydrogen peroxide production during fatty acid oxidation in rat skeletal muscle mitochondria. Free. Radic. Biol. Med. 2013, 61, 298–309. [Google Scholar] [CrossRef]
  33. Quinlan, C.L.; Perevoshchikova, I.V.; Hey-Mogensen, M.; Orr, A.L.; Brand, M.D. Sites of reactive oxygen species generation by mitochondria oxidizing different substrates. Redox Biol. 2013, 1, 304–312. [Google Scholar] [CrossRef] [PubMed]
  34. Panov, A.V. Synergistic Oxidation of Fatty Acids, Glucose and Amino Acids Metabolites by Isolated Rat Heart Mitochondria. EC Cardiology 2018, 5, 98–208. [Google Scholar]
  35. Panov, A.; Orynbayeva, Z. Determination of mitochondrial metabolic phenotype through investigation of the intrinsic inhibition of succinate dehydrogenase. Anal. Biochem. 2018, 552, 30–37. [Google Scholar] [CrossRef] [PubMed]
  36. Ernster, L.; Dallner, G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. et Biophys. Acta (BBA) - Mol. Basis Dis. 1995, 1271, 195–204. [Google Scholar] [CrossRef]
  37. Rydström, J. Mitochondrial NADPH, transhydrogenase and disease. Biochim. et Biophys. Acta (BBA) - Bioenerg. 2006, 1757, 721–726. [Google Scholar] [CrossRef] [PubMed]
  38. Francisco, A.; Ronchi, J.A.; Navarro, C.D.C.; Figueira, T.R.; Castilho, R.F. Nicotinamide nucleotide transhydrogenase is required for brain mitochondrial redox balance under hampered energy substrate metabolism and high-fat diet. J. Neurochem. 2018, 147, 663–677. [Google Scholar] [CrossRef] [PubMed]
  39. Ronchi, J.A.; Francisco, A.; Passos, L.A.C.; Figueira, T.R.; Castilho, R.F. The Contribution of Nicotinamide Nucleotide Transhydrogenase to Peroxide Detoxification Is Dependent on the Respiratory State and Counterbalanced by Other Sources of NADPH in Liver Mitochondria. J. Biol. Chem. 2016, 291, 20173–20187. [Google Scholar] [CrossRef]
  40. Muhleip, A.; Flygaard, R.K.; Baradaran, R.; Haapanen, O.; Gruhl, T.; Tobiasson, V.; et al. Structural basis of mitochondrial membrane bending by the I-II-III(2)-IV(2) supercomplex. Nature 2023, 615, 934–938. [Google Scholar] [CrossRef] [PubMed]
  41. Muhleip, A.; McComas, S.E.; Amunts, A. Structure of a mitochondrial ATP synthase with bound native cardiolipin. Elife 2019, 8, e51179. [Google Scholar] [CrossRef]
  42. Mileykovskaya, E.; Dowhan, W. Cardiolipin membrane domains in prokaryotes and eukaryotes. Biochim. et Biophys. Acta (BBA) - Biomembr. 2009, 1788, 2084–2091. [Google Scholar] [CrossRef]
  43. Harris, S.; Balaban, R.; Barrett, L.; Mandel, L. Mitochondrial respiratory capacity and Na+- and K+-dependent adenosine triphosphatase-mediated ion transport in the intact renal cell. J. Biol. Chem. 1981, 256, 10319–10328. [Google Scholar] [CrossRef]
  44. Mileykovskaya, E.; Dowhan, W. Cardiolipin-dependent formation of mitochondrial respiratory supercomplexes. Chem. Phys. Lipids 2013, 179, 42–48. [Google Scholar] [CrossRef] [PubMed]
  45. Schlame, M.; Rua, D.; Greenberg, M.L. The biosynthesis and functional role of cardiolipin. Prog. Lipid Res. 2000, 39, 257–288. [Google Scholar] [CrossRef]
  46. Harner, M.; Körner, C.; Walther, D.; Mokranjac, D.; Kaesmacher, J.; Welsch, U.; Griffith, J.; Mann, M.; Reggiori, F.; Neupert, W. The mitochondrial contact site complex, a determinant of mitochondrial architecture. EMBO J. 2011, 30, 4356–4370. [Google Scholar] [CrossRef]
  47. van der Laan, M.; E Horvath, S.; Pfanner, N. Mitochondrial contact site and cristae organizing system. Curr. Opin. Cell Biol. 2016, 41, 33–42. [Google Scholar] [CrossRef] [PubMed]
  48. Lewis, R.N.; McElhaney, R.N. The physicochemical properties of cardiolipin bilayers and cardiolipin-containing lipid membranes. Biochim. et Biophys. Acta (BBA) - Biomembr. 2009, 1788, 2069–2079. [Google Scholar] [CrossRef] [PubMed]
  49. Panov, A. Perhydroxyl Radical (HO2•) as Inducer of the Isoprostane Lipid Peroxidation in Mitochondria. Mol. Biol. 2018, 52, 295–305. [Google Scholar] [CrossRef]
  50. Panov, A.V. , Dikalov, S.I. Cardiolipin, Perhydroxyl Radicals and Lipid Peroxidation in Mitochondrial Dysfunctions and Aging. Oxidative Medicine and Cellular Longevity 2020, 2020, 1323028. [Google Scholar] [CrossRef]
Preprints 94643 g001
Figure 1. Schematic presentation of the mitochondrial respiratory chain and ATP synthase. Mitochondrial pathways of electron flow resulting from the substrates and inhibitors used in the study. Substrates used were glutamate/malate (which generates NADH via the tricarboxylic acid cycle, feeding into complex I), succinate (which feeds electrons directly into complex II), and palmitoyl-carnitine (which feeds electrons into the ETC via acyl-CoA dehydrogenase as well as through the β-oxidation pathway). Inhibitors used were rotenone, which inhibits complex I at the downstream Q binding site, malonate - a competitive inhibitor of complex II), and antimycin A, a complex III inhibitor that prevents electron flow to the QI site of complex III, thus stabilizing QH* at the QO. The figure was adapted from [17].
Figure 1. Schematic presentation of the mitochondrial respiratory chain and ATP synthase. Mitochondrial pathways of electron flow resulting from the substrates and inhibitors used in the study. Substrates used were glutamate/malate (which generates NADH via the tricarboxylic acid cycle, feeding into complex I), succinate (which feeds electrons directly into complex II), and palmitoyl-carnitine (which feeds electrons into the ETC via acyl-CoA dehydrogenase as well as through the β-oxidation pathway). Inhibitors used were rotenone, which inhibits complex I at the downstream Q binding site, malonate - a competitive inhibitor of complex II), and antimycin A, a complex III inhibitor that prevents electron flow to the QI site of complex III, thus stabilizing QH* at the QO. The figure was adapted from [17].
Preprints 94643 g001
Preprints 94643 g002
Figure 2. Schematic presentation of the respirasome. View from the matrix side on the two large supercomplexes and one smaller supercomplex. Complexes I, III, and IV are integral proteins. They penetrate the inner membrane and work as proton pumps. The Figure is based on the data presented in [5]. Figure 6 and Figure 9 show more clearly how the respirasome’s supercomplexes might integrate into the inner membrane of mitochondria.
Figure 2. Schematic presentation of the respirasome. View from the matrix side on the two large supercomplexes and one smaller supercomplex. Complexes I, III, and IV are integral proteins. They penetrate the inner membrane and work as proton pumps. The Figure is based on the data presented in [5]. Figure 6 and Figure 9 show more clearly how the respirasome’s supercomplexes might integrate into the inner membrane of mitochondria.
Preprints 94643 g002
Preprints 94643 g003
Figure 3. A schematic model of organizing respiratory chain complexes into a respiratory string. The basic unit (lower left) consists of two copies of complex I (blue), one copy of complex III2 (red), and two copies of complex IV (yellow). The figure was adapted from [19].
Figure 3. A schematic model of organizing respiratory chain complexes into a respiratory string. The basic unit (lower left) consists of two copies of complex I (blue), one copy of complex III2 (red), and two copies of complex IV (yellow). The figure was adapted from [19].
Preprints 94643 g003
Preprints 94643 g004
Figure 4. Structure of the mitochondrial OXPHOS system and cristae membrane illustrating a proton transfer pathway. (A) The cluster of components of the OXPHOS system at the bends of the cristae of heart mitochondria. Yellow—ATP synthase dimers, blue—complex I, purple—complex III dimers, green—complex IV, and grey—lipid membrane. (B) A dedicated direction of proton transfer between rows of proton pumps and ATP synthases. (C) Schematic reconstruction of the cluster in the OXPHOS system on the membrane fold and a pathway of the lateral transfer of protons from the respirasome to ATP synthase. The area of increased curvature of the membrane is enriched with CL molecules. The figure was adapted from [21].
Figure 4. Structure of the mitochondrial OXPHOS system and cristae membrane illustrating a proton transfer pathway. (A) The cluster of components of the OXPHOS system at the bends of the cristae of heart mitochondria. Yellow—ATP synthase dimers, blue—complex I, purple—complex III dimers, green—complex IV, and grey—lipid membrane. (B) A dedicated direction of proton transfer between rows of proton pumps and ATP synthases. (C) Schematic reconstruction of the cluster in the OXPHOS system on the membrane fold and a pathway of the lateral transfer of protons from the respirasome to ATP synthase. The area of increased curvature of the membrane is enriched with CL molecules. The figure was adapted from [21].
Preprints 94643 g004
Preprints 94643 g005
Figure 5. The sequence of reactions of formation of the trans-double bond between C-2 and C-3 thioesters of fatty acids and reduction of ubiquinone during the work of acyl-CoA dehydrogenase complex.
Figure 5. The sequence of reactions of formation of the trans-double bond between C-2 and C-3 thioesters of fatty acids and reduction of ubiquinone during the work of acyl-CoA dehydrogenase complex.
Preprints 94643 g005
Preprints 94643 g006
Figure 6. Without β-oxidation of FAs, succinate dehydrogenase is the only source of ubiquinol, and the mitochondrial metabolism becomes predominantly catabolic. Designations: Q - ubiquinone, the oxidized form of coenzyme Q: QH2- -ubiquinol, the reduced form of coenzyme Q. The figure was adapted from [13].
Figure 6. Without β-oxidation of FAs, succinate dehydrogenase is the only source of ubiquinol, and the mitochondrial metabolism becomes predominantly catabolic. Designations: Q - ubiquinone, the oxidized form of coenzyme Q: QH2- -ubiquinol, the reduced form of coenzyme Q. The figure was adapted from [13].
Preprints 94643 g006
Preprints 94643 g007
Figure 7. Oxidation by rat heart mitochondria of major substrates: A. pyruvate 2.5 mM+ malate 2 mM, B. glutamate 5 mM + malate, C. glutamate + pyruvate + malate, D. succinate 5 mM, no rotenone, E. Succinate + glutamate, F. palmitoyl-carnitine 25 µM. Incubation conditions and experimental details are described in [14]. Additions: ADP 150 µM, CCCP 0.5 µM, rat heart mitochondria 0.3 mg, provide only (dithiothreitol) 10 µl of saturated solution. The figure was adapted from [34].
Figure 7. Oxidation by rat heart mitochondria of major substrates: A. pyruvate 2.5 mM+ malate 2 mM, B. glutamate 5 mM + malate, C. glutamate + pyruvate + malate, D. succinate 5 mM, no rotenone, E. Succinate + glutamate, F. palmitoyl-carnitine 25 µM. Incubation conditions and experimental details are described in [14]. Additions: ADP 150 µM, CCCP 0.5 µM, rat heart mitochondria 0.3 mg, provide only (dithiothreitol) 10 µl of saturated solution. The figure was adapted from [34].
Preprints 94643 g007
Preprints 94643 g008
Figure 8. Oxidation by rat heart mitochondria palmitoyl-carnitine in the presence of supporting substrates: A. palmitoyl-carnitine 25 µM + succinate 5 mM; B. palmitoyl-carnitine 25 µM + pyruvate 2.5 mM + malate 2mM, C. palmitoyl-carnitine 25 µM + glutamate 5mM + malate 2 mM. The figure was adapted from [34].
Figure 8. Oxidation by rat heart mitochondria palmitoyl-carnitine in the presence of supporting substrates: A. palmitoyl-carnitine 25 µM + succinate 5 mM; B. palmitoyl-carnitine 25 µM + pyruvate 2.5 mM + malate 2mM, C. palmitoyl-carnitine 25 µM + glutamate 5mM + malate 2 mM. The figure was adapted from [34].
Preprints 94643 g008
Preprints 94643 g009
Figure 9. Functioning of respirasome and the Krebs Cycle during active β-oxidation of long-chain fatty acids. Abbreviations: Acyl-CoA DHC - acyl-CoA dehydrogenase complex, which includes three enzymes: acyl-CoA dehydrogenase, electron transfer flavoprotein (ETF), electron-transferring-flavoprotein dehydrogenase (ETFDH); PEP - phosphoenolpyruvate; TFP – trifunctional protein of the β-oxidation of fatty acids system; SDH – succinate dehydrogenase; Q – ubiquinone, oxidized form of coenzyme Q; QH2 - ubiquinol, reduced form of coenzyme Q. The figure adapted from [13].
Figure 9. Functioning of respirasome and the Krebs Cycle during active β-oxidation of long-chain fatty acids. Abbreviations: Acyl-CoA DHC - acyl-CoA dehydrogenase complex, which includes three enzymes: acyl-CoA dehydrogenase, electron transfer flavoprotein (ETF), electron-transferring-flavoprotein dehydrogenase (ETFDH); PEP - phosphoenolpyruvate; TFP – trifunctional protein of the β-oxidation of fatty acids system; SDH – succinate dehydrogenase; Q – ubiquinone, oxidized form of coenzyme Q; QH2 - ubiquinol, reduced form of coenzyme Q. The figure adapted from [13].
Preprints 94643 g009
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated